Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Antioxidant activity against reactive oxygen species" does **not** refer to a single molecular target such as an enzyme or receptor but rather describes the collective ability of various molecules—both enzymatic and nonenzymatic—to neutralize reactive oxygen species (ROS) within cells. ROS are highly reactive derivatives of oxygen that play dual roles in biology: at low concentrations they function in cell signaling; at high concentrations they cause cellular damage leading to lipid peroxidation, protein modification, DNA/RNA oxidation, enzyme inhibition, apoptosis activation—and ultimately contribute to aging and many diseases if not adequately controlled by antioxidants. The main enzymatic antioxidants include superoxide dismutases (SODs), catalases, peroxidases such as glutathione peroxidase; nonenzymatic antioxidants include molecules like ascorbic acid (vitamin C), tocopherols/tocotrienols (vitamin E), glutathione (GSH), flavonoids like quercetin/curcumin. These systems work together in complex cycles—such as the water-water cycle or Asc-GSH cycle—to maintain redox balance within different subcellular compartments. Because "antioxidant activity against reactive oxygen species" is not itself a discrete molecular entity but rather an emergent property arising from multiple biochemical systems acting together across various tissues/cell types/organisms—it should **not** be considered a canonical therapeutic target for drug discovery purposes.[1][3]
Antioxidants act by neutralizing reactive oxygen species through electron donation or hydrogen atom transfer, thereby preventing oxidative damage to cellular components such as lipids, proteins, and nucleic acids. Some antioxidants also upregulate endogenous antioxidant enzymes or modulate redox-sensitive signaling pathways like Keap1-Nrf2.[1][2][3][5]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant activity against reactive oxygen species.